AU8817498A - Pharmaceutical composition containing midazolam - Google Patents

Pharmaceutical composition containing midazolam

Info

Publication number
AU8817498A
AU8817498A AU88174/98A AU8817498A AU8817498A AU 8817498 A AU8817498 A AU 8817498A AU 88174/98 A AU88174/98 A AU 88174/98A AU 8817498 A AU8817498 A AU 8817498A AU 8817498 A AU8817498 A AU 8817498A
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
composition containing
containing midazolam
midazolam
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU88174/98A
Inventor
Ian Mcmillan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent UK Swindon Encaps Ltd
Original Assignee
Catalent UK Swindon Encaps Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent UK Swindon Encaps Ltd filed Critical Catalent UK Swindon Encaps Ltd
Publication of AU8817498A publication Critical patent/AU8817498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU88174/98A 1997-08-21 1998-08-20 Pharmaceutical composition containing midazolam Abandoned AU8817498A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9717770 1997-08-21
GBGB9717770.3A GB9717770D0 (en) 1997-08-21 1997-08-21 Pharmaceutical composition
PCT/GB1998/002511 WO1999009989A1 (en) 1997-08-21 1998-08-20 Pharmaceutical composition containing midazolam

Publications (1)

Publication Number Publication Date
AU8817498A true AU8817498A (en) 1999-03-16

Family

ID=10817853

Family Applications (1)

Application Number Title Priority Date Filing Date
AU88174/98A Abandoned AU8817498A (en) 1997-08-21 1998-08-20 Pharmaceutical composition containing midazolam

Country Status (3)

Country Link
AU (1) AU8817498A (en)
GB (1) GB9717770D0 (en)
WO (1) WO1999009989A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130964D0 (en) * 2001-12-24 2002-02-13 Special Products Ltd Pharmaceutical composition
WO2006002836A1 (en) * 2004-07-01 2006-01-12 Losan Pharma Gmbh Effervescent compositions of sleeping drugs
CN107811980B (en) 2009-10-30 2021-06-18 Ix 生物医药有限公司 Fast dissolving solid dosage form
JP2018521139A (en) * 2015-07-16 2018-08-02 スウィップ エービーＳｗｉｐｐ Ａｂ Midazolam composition for buccal administration in the treatment of seizures to obtain rapid onset of action

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
EP0084705B1 (en) * 1981-12-11 1987-01-14 JOHN WYETH & BROTHER LIMITED Process for preparing solid shaped articles
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
US5122127A (en) * 1985-05-01 1992-06-16 University Of Utah Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
CZ297382B6 (en) * 1995-03-02 2006-11-15 R.P. Scherer Limited Rapidly dispersing oral solid dosage form of pharmaceutical for the treatment of Parkinson's disease

Also Published As

Publication number Publication date
GB9717770D0 (en) 1997-10-29
WO1999009989A1 (en) 1999-03-04

Similar Documents

Publication Publication Date Title
HUP9701554D0 (en) Pharmaceutical composition containing plazma proteins
AU6740298A (en) Pharmaceutical composition
AU1157599A (en) Pyrimidinone compounds and pharmaceutical compositions containing them
HUP0001339A3 (en) Pharmaceutical aerosol composition
AU8107998A (en) Pharmaceutical compositions
AU8591898A (en) Pharmaceutical compounds
AU7904998A (en) Pharmaceutical composition containing peptichemio
GB9717444D0 (en) Pharmaceutical composition
HUP0002455A3 (en) Gastric-retained pharmaceutical composition
AU9343098A (en) Pharmaceutical composition
AU7937500A (en) Pharmaceutical composition containing midazolam
AU1044799A (en) Pharmaceutical composition containing zafirlukast
AU5384699A (en) Basic peptides and pharmaceutical compositions containing same
AU1172097A (en) Pharmaceutical composition containing trehalose
AUPP332898A0 (en) Pharmaceutical composition
AU1509799A (en) Pharmaceutical composition containing cyclosporin
AU8817498A (en) Pharmaceutical composition containing midazolam
GB2321190B (en) Pharmaceutical composition
GB9726781D0 (en) Pharmaceutical composition
AUPO590197A0 (en) Pharmaceutical composition
AUPO598497A0 (en) Pharmaceutical composition
AU7826198A (en) Pharmaceutical compositions containing alpha-tocopherylphosphocholine
HU9802107D0 (en) Pharmaceutical composition containing plazma proteins
AUPO833297A0 (en) Pharmaceutical compositions
HU9701598D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase